Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis

Matteo Ravaioli; Gian Luca Grazi; Alfonso Principe; Giorgio Ercolani; Matteo Cescon; Andrea Gardini; Giovanni Varotti; Massimo Del Gaudio; Antonino Cavallari

Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis

Matteo Ravaioli, Gian Luca Grazi, Alfonso Principe, Giorgio Ercolani, Matteo Cescon, Andrea Gardini, Giovanni Varotti, Massimo Del Gaudio, Antonino Cavallari

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

Background/Aims: The purpose of this study was to evaluate the clinical usefulness of the preoperative lidocaine test (MEGX) in cirrhotic patients who were candidates for curative liver resection for hepatocellular carcinoma. Methodology: To evaluate whether MEGX was related to postoperative complications, a retrospective analysis was carried out on 51 patients, in whom a preoperative lidocaine test was available. They were divided into two groups according to a MEGX value less (22 patients, group A) or more (29 patients, group B) than 25ng/mL. Results: The two groups of patients were comparable for the preoperative clinical parameters and the surgical procedures. Patients in group A had a significantly higher rate of postoperative complications (73% vs. 28%, p

Original language	English
Pages (from-to)	1552-1555
Number of pages	4
Journal	Hepato-Gastroenterology
Volume	50
Issue number	53
Publication status	Published - Sept 2003

Keywords

Cirrhosis
Hepatic resection
Hepatocellular carcinoma
Lidocaine test
Liver function
MEGX
Postoperative complications

ASJC Scopus subject areas

Gastroenterology

Cite this

@article{7d2a689810b64f0eb807655d348a7e42,

title = "Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis",

abstract = "Background/Aims: The purpose of this study was to evaluate the clinical usefulness of the preoperative lidocaine test (MEGX) in cirrhotic patients who were candidates for curative liver resection for hepatocellular carcinoma. Methodology: To evaluate whether MEGX was related to postoperative complications, a retrospective analysis was carried out on 51 patients, in whom a preoperative lidocaine test was available. They were divided into two groups according to a MEGX value less (22 patients, group A) or more (29 patients, group B) than 25ng/mL. Results: The two groups of patients were comparable for the preoperative clinical parameters and the surgical procedures. Patients in group A had a significantly higher rate of postoperative complications (73% vs. 28%, p",

keywords = "Cirrhosis, Hepatic resection, Hepatocellular carcinoma, Lidocaine test, Liver function, MEGX, Postoperative complications",

author = "Matteo Ravaioli and Grazi, {Gian Luca} and Alfonso Principe and Giorgio Ercolani and Matteo Cescon and Andrea Gardini and Giovanni Varotti and {Del Gaudio}, Massimo and Antonino Cavallari",

year = "2003",

month = sep,

language = "English",

volume = "50",

pages = "1552--1555",

journal = "Acta hepato-splenologica",

issn = "0172-6390",

publisher = "H.G.E. Update Medical Publishing Ltd.",

number = "53",

}

TY - JOUR

T1 - Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis

AU - Ravaioli, Matteo

AU - Grazi, Gian Luca

AU - Principe, Alfonso

AU - Ercolani, Giorgio

AU - Cescon, Matteo

AU - Gardini, Andrea

AU - Varotti, Giovanni

AU - Del Gaudio, Massimo

AU - Cavallari, Antonino

PY - 2003/9

Y1 - 2003/9

N2 - Background/Aims: The purpose of this study was to evaluate the clinical usefulness of the preoperative lidocaine test (MEGX) in cirrhotic patients who were candidates for curative liver resection for hepatocellular carcinoma. Methodology: To evaluate whether MEGX was related to postoperative complications, a retrospective analysis was carried out on 51 patients, in whom a preoperative lidocaine test was available. They were divided into two groups according to a MEGX value less (22 patients, group A) or more (29 patients, group B) than 25ng/mL. Results: The two groups of patients were comparable for the preoperative clinical parameters and the surgical procedures. Patients in group A had a significantly higher rate of postoperative complications (73% vs. 28%, p

AB - Background/Aims: The purpose of this study was to evaluate the clinical usefulness of the preoperative lidocaine test (MEGX) in cirrhotic patients who were candidates for curative liver resection for hepatocellular carcinoma. Methodology: To evaluate whether MEGX was related to postoperative complications, a retrospective analysis was carried out on 51 patients, in whom a preoperative lidocaine test was available. They were divided into two groups according to a MEGX value less (22 patients, group A) or more (29 patients, group B) than 25ng/mL. Results: The two groups of patients were comparable for the preoperative clinical parameters and the surgical procedures. Patients in group A had a significantly higher rate of postoperative complications (73% vs. 28%, p

KW - Cirrhosis

KW - Hepatic resection

KW - Hepatocellular carcinoma

KW - Lidocaine test

KW - Liver function

KW - MEGX

KW - Postoperative complications

UR - http://www.scopus.com/inward/record.url?scp=0141651557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141651557&partnerID=8YFLogxK

M3 - Article

C2 - 14571784

AN - SCOPUS:0141651557

SN - 0172-6390

VL - 50

SP - 1552

EP - 1555

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

IS - 53

ER -

Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this